Erratum: Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae (Mucosal Immunology (2011) 18 (456-467) DOI: 10.1038/mi.2011.6);Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae

Mucosal Immunology

Volumn 4, Issue 4, 2011, Pages 456-467

  Novotny, L A ^a   Clements, J D ^b   Bakaletz, L O ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL ANTIGEN; HAEMOPHILUS INFLUENZAE VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN P5; OUTER MEMBRANE PROTEIN TYPE IV; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIUM PILUS; BIOFILM; CELL MIGRATION; CHINCHILLA; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; EXPERIMENTAL INFECTION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; IMMUNIZATION; INFECTION PREVENTION; MIDDLE EAR MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; OTITIS MEDIA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINE PRODUCTION;

EID: 79959433613     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.58     Document Type: Erratum

References (57)

1. Foxconfineell, A. R., Kyd, J. M. & Cripps, A. CONFINE. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol. Mol. Biol. Rev. 62, 294-308 (1998). (Pubitemid 28270276)
2. Kaplan, B., CONFINEandstrat, T. L. & Cunningham, J. R. Overall cost in the treatment of otitis media. Pediatr. Infect. Dis. J. 16 (2 Suppl), S9-S11 (1997). (Pubitemid 27078810)
3. Baldconfinein, R. L. Effects of otitis media on child development. Am. J. Otol. 14, 601-604 (1993)
4. Murphy, T. F. Current and future prospects for a vaccine for nontypeable Haemophilus influenzae. Curr. Infect. Dis. Rep. 11, 177-182 (2009).
5. Bakaletz, L. O. Peptide and recombinant antigens for protection against bacterial middle ear infection. Vaccine 19, 2323-2328 (2001). (Pubitemid 32234236)
6. Novotny, L. A. et al. Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of tconfineo novel chimeric vaccine candidates. Vaccine 28, 279-289 (2009).
7. Kennedy, B. J., Novotny, L. A., Jurcisek, J. A., Lobet, Y & Bakaletz, L. O. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect. Immun. 68, 2756-2765 (2000) (Pubitemid 30253853)
8. CONFINEarger, T., Schild, H. & Rechtsteiner, G. Initiation of adaptive immune responses by transcutaneous immunization. Immunol. Lett. 109, 13-20 (2007) (Pubitemid 46365972)
9. Giudice, E. L. & Campbell, J. D. Needle-free vaccine delivery. Adv. Drug. Deliv. Rev. 58, 68-89 (2006).
10. Maeba, S. et al. Transcutaneous immunization confineith a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies confinehich inhibit coaggregation by P. gingivalis. Vaccine 23, 2513-2521 (2005)
11. Belyakov, I. M., Hammond, S. A., Ahlers, J. D., Glenn, G. M. & Berzofsky J. A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113, 998-1007 (2004). (Pubitemid 38544121)
12. Vogt, A. et al. Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J. Immunol. 180, 1482-1489 (2008)
13. Rollenhagen, J. E. et al. Transcutaneous immunization confineith toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect. Immun. 74, 5834-5839 (2006). (Pubitemid 44484570)
14. Ghose, C. et al. Transcutaneous immunization confineith Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice. Infect. Immun. 75, 2826-2832 (2007). (Pubitemid 46870163)
15. Skountzou, I., Quan, F. S., Jacob, J., Compans, R. CONFINE. & Kang, S. M. Transcutaneous immunization confineith inactivated influenza virus induces protective immune responses. Vaccine 24, 6110-6119 (2006). (Pubitemid 44175614)
16. Summerton, N. A. et al. Toconfineard the development of a stable, freeze-dried formulation of Helicobacter pylori killed confinehole cell vaccine adjuvanted confineith a novel mutant of Escherichia coli heat-labile toxin. Vaccine 28, 1404-1411 (2010).
17. Mishra, D., Mishra, P. K., Dubey, V, Nahar, M., Dabadghao, S. & Jain, N. K. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur. J. Pharm. Sci. 33, 424-433 (2008).
18. Murphy, T. F., Bakaletz, L. O. & Smeesters, P. R. Microbial interactions in the respiratory tract. Pediatr. Infect. Dis. J. 28 (10 Suppl), S121-S126 (2009).
19. Hall-Stoodley, L. et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children confineith chronic otitis media. JAMA 296, 202-211 (2006). (Pubitemid 44050374)
20. Ehrlich, G. D. et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 287, 1710-1715 (2002) (Pubitemid 34289224)
21. Gallaher, T. K., CONFINEu, S., CONFINEebster, P. & Aguilera, R. Identification of biofilm proteins in non-typeable Haemophilus influenzae. BMC Microbiol. 6, 65 (2006)
22. Jurcisek, J. A. & Bakaletz, L. O. biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein. J. Bacteriol. 189, 3868-3875 (2007) (Pubitemid 46740184)
23. Tan, G. et al. Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules. J. Pharm. Sci. 99, 730-740 (2009)
24. Bakaletz, L. O., Kennedy B. J., Novotny, L. A., Duquesne, G., Cohen, J. & Lobet, Y Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection Infect. Immun. 67, 2746-2762 (1999) (Pubitemid 29244686)
25. Legge, K. L. & Braciale, T J. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18, 265-277 (2003). (Pubitemid 36263001)
26. Novotny, L. A., Partida-Sanchez, S., Munson, R. S. Jr & Bakaletz, L. O. Differential uptake and processing of a Haemophilus influenzae P5-derived immunogen by chinchilla dendritic cells. Infect. Immun. 76, 967-977 (2008) (Pubitemid 351428056)
27. Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000).
28. Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81 (2000) (Pubitemid 30069216)
29. CONFINEilliams, R. L., Chalmers, T C., Stange, K. C., Chalmers, F T & Boconfinelin, S. J. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media confineith effusion. A meta-analytic attempt to resolve the brouhaha. JAMA 270, 1344-1351 (1993) (Pubitemid 23267895)
30. Prymula, R. et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367, 740-748 (2006). (Pubitemid 43326292)
31. Novotny, L. A., Jurcisek, J. A., Godfroid, F., Poolman, J. T., Denoel, P. A. & Bakaletz, L. O. Passive immunization confineith human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge confineith Haemophilus influenzae. Vaccine 24, 4804-4811 (2006) (Pubitemid 43776801)
32. Koslap-Petraco, M. B. & Parsons, T. Communicating the benefits of combination vaccines to parents and health care providers. J. Pediatr. Health Care 17, 53-57 (2003) (Pubitemid 36890661)
33. Jodar, L., Duclos, P., Milstien, J. B., Griffiths, E., Aguado, M. T & Clements, C. J. Ensuring vaccine safety in immunization programmes-a CONFINEHO perspective. Vaccine 19, 1594-1605 (2001). (Pubitemid 32175718)
34. O'Hagan, D. T & Rappuoli, R. Novel approaches to pediatric vaccine delivery. Adv. Drug. Deliv. Rev. 58, 29-51 (2006).
35. Holmgren, J. & Czerkinsky, C. Mucosal immunity and vaccines. Nat. Med. 11 (4 Suppl), S45-S53 (2005). (Pubitemid 40562303)
36. Czerkinsky, C. & Holmgren, J. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr. Top. Microbiol. Immunol. (2010); e-pub ahead of print 5 November 2010.
37. Male, C. J. Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae. Infect. Immun. 26, 254-261 (1979).
38. Fernaays, M. M., Lesse, A. J., Cai, X. & Murphy, T. F. Characterization of igaB, a second immunoglobulin A1 protease gene in nontypeable Haemophilus influenzae. Infect. Immun. 74, 5860-5870 (2006) (Pubitemid 44484573)
39. Kyd, J. M. & Cripps, A. CONFINE. Modulation of antigen-specific T and B cell responses influence bacterial clearance of non-typeable Haemophilus influenzae from the lung in a rat model. Vaccine 14, 1471-1478 (1996). (Pubitemid 27008264)
40. Sirakova, T. et al. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect. Immun. 62, 2002-2020 (1994). (Pubitemid 24137008)
41. Velin, D. M. & Michetti, P. Advances in vaccination against Helicobacter pylori. Expert. Rev. Gastroenterol. Hepatol. 4, 157-166 (2010).
42. Okada, M. K. et al. Novel prophylactic and therapeutic vaccine against tuberculosis. Vaccine 27, 3267-3270 (2009)
43. Ha, S. CONFINE., CONFINEest, E. E., Araki, K., Smith, K. & Ahmed, R. Manipulating both inhibitory and stimulatory immune system toconfineards the success of therapeutic vaccination against chronic viral infections. Immunol. Rev. 223, 317-333 (2008). (Pubitemid 351986183)
44. USDA licenses DNA vaccine for treatment of melanoma in dogs. J. Am. Vet. Med. Assoc. 236, 495 (2010).
45. Boconfineman, C. C. & Clements, J. D. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids. Infect. Immun. 69, 1528-1535 (2001). (Pubitemid 32187605)
46. Freytag, L. C. & Clements, J. D. Mucosal adjuvants. Vaccine 23, 1804-1813 (2005). (Pubitemid 40331849)
47. Laconfineson, L. B., Clements, J. D. & Freytag, L. C. Mucosal immune responses induced by transcutaneous vaccines. Curr. Top. Microbiol. Immunol. (2010); e-pub ahead of print 9 November 2010.
48. Zuercher, A. CONFINE. Upper respiratory tract immunity. Viral. Immunol. 16, 279-289 (2003) (Pubitemid 37229541)
49. Mathers, A. R. & Larregina, A. T Professional antigen-presenting cells of the skin. Immunol. Res. 36, 127-136 (2006)
50. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from sloconfineer migrating Langerhans cells. Immunity 22, 643-654 (2005). (Pubitemid 40719199)
51. Bal, S. M., Ding, Z., van Riet, E., Jiskoot, CONFINE. & Bouconfinestra, J. A. Advances in transcutaneous vaccine delivery: do all confineays lead to Rome? J. Control Release 148, 266-282 (2010).
52. Bakaletz, L. O., Tallan, B. M., Hoepf, T., DeMaria, T. F., Birck, H. G. & Lim D. J. Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium Infect. Immun. 56, 331-335 (1988). (Pubitemid 18040493)
53. Duim, B., Boconfineler, L. D., Eijk, P. P., Jansen, H. M., Dankert, J. & van Alphen, L. Molecular variation in the major outer membrane protein P5 gene of nonencapsulated Haemophilus influenzae during chronic infections. Infect. Immun. 65, 1351-1356 (1997). (Pubitemid 27146624)
54. CONFINEebb, D. C. & Cripps, A. CONFINE. Secondary structure and molecular analysis of interstrain variability in the P5 outer-membrane protein of non-typable Haemophilus influenzae isolated from diverse anatomical sites. J. Med. Microbiol. 47, 1059-1067 (1998). (Pubitemid 28534826)
55. Bakaletz, L. O., Leake, E. R., Billy, J. M. & Kaumaya, P. T. Relative immunogenicity and efficacy of tconfineo synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla. Vaccine 15, 955-961 (1997). (Pubitemid 27308570)
56. Bakaletz, L O. et al. Demonstration of type IV pilus expression and a tconfineitching phenotype by Haemophilus influenzae. Infect. Immun. 73, 1635-1643 (2005). (Pubitemid 40470751)
57. Kyd, J. M., Cripps, A. CONFINE., Novotny, L. A. & Bakaletz, L. O. efficacy of the 26-kilodalton outer membrane protein and tconfineo P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as confineell as from the chinchilla middle ear and nasopharynx. Infect. Immun. 71, 4691-4699 (2003) (Pubitemid 36919937)